Valiant Organics Ltd

Valiant Organics Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Valiant Organics Ltd

₹ 386 1.30%
24 Jul - close price
valiantorganics.com BSE: 540145 NSE: VALIANTORG
About

Incorporated in 1984, Valiant Organics
Ltd manufactures and deals in specialty chemicals and pharma intermediates[1]

Key Points

Business Overview:[1][2][3]
VOL is is promoted by Gogri, Chedda and Gala families. It is a manufacturer and seller of specialty chemicals. It is one of the largest manufacturers of chlorophenol derivatives, Benzene derivatives, PNA, PAP, Ortho Anisidine and Para Anisidine. Company has a client base across Pharmaceuticals, Dyes & Pigments, Agrochemicals, specialty chemicals, and veterinary medications

Website BSE NSE
  • Market Cap ₹ 1,066 Cr.
  • Current Price ₹ 386
  • High / Low ₹ 565 / 368
  • Stock P/E
  • Book Value ₹ 264
  • Dividend Yield 0.26 %
  • ROCE 1.11 %
  • ROE -0.88 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 0.88% over past five years.
  • Company has a low return on equity of 10.0% over last 3 years.
  • Promoter holding has decreased over last 3 years: -3.88%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
234 244 273 288 348 266 264 250 271 202 203 141 177
176 194 226 238 291 234 222 212 219 178 188 139 179
Operating Profit 58 50 47 50 57 32 42 38 52 24 15 3 -2
OPM % 25% 21% 17% 17% 16% 12% 16% 15% 19% 12% 8% 2% -1%
1 1 2 3 2 2 2 6 3 9 4 0 -7
Interest 1 2 2 1 2 3 3 3 3 4 4 4 7
Depreciation 6 7 7 8 8 7 7 7 8 9 9 9 9
Profit before tax 53 43 41 44 49 24 34 35 44 20 6 -10 -25
Tax % 34% 33% 26% 26% 25% 30% 25% 25% 23% 25% 26% -20% -20%
35 29 30 32 37 17 26 26 34 15 5 -8 -20
EPS in Rs 10.16 9.81 9.42 11.03 11.45 5.68 7.72 8.09 10.96 4.57 1.58 -2.86 -7.32
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
692 675 755 1,153 1,052 723
511 494 550 948 888 686
Operating Profit 181 181 205 205 164 37
OPM % 26% 27% 27% 18% 16% 5%
8 6 6 7 13 6
Interest 4 3 5 6 11 16
Depreciation 14 16 21 30 29 35
Profit before tax 171 168 185 176 137 -9
Tax % 29% 25% 29% 27% 25% -3%
121 126 131 128 103 -8
EPS in Rs 103.65 51.00 42.19 41.72 32.45 -3.04
Dividend Payout % 6% 11% 12% 8% 3% 0%
Compounded Sales Growth
10 Years: %
5 Years: 1%
3 Years: -1%
TTM: -31%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -107%
Stock Price CAGR
10 Years: %
5 Years: -10%
3 Years: -35%
1 Year: -24%
Return on Equity
10 Years: %
5 Years: 16%
3 Years: 10%
Last Year: -1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 6 12 27 27 27 28
Reserves 254 374 475 586 662 702
77 140 210 364 274 257
112 143 165 216 276 262
Total Liabilities 448 669 876 1,192 1,239 1,248
150 276 510 543 670 643
CWIP 66 129 46 112 71 86
Investments 12 23 6 8 41 99
221 241 314 529 457 420
Total Assets 448 669 876 1,192 1,239 1,248

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
76 161 115 -31 238 84
-86 -184 -159 -124 -143 -65
1 27 49 167 -112 -23
Net Cash Flow -9 5 5 12 -17 -4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 75 72 76 102 88 106
Inventory Days 44 42 66 54 68 85
Days Payable 69 82 97 63 89 155
Cash Conversion Cycle 50 32 44 93 67 36
Working Capital Days 63 42 63 103 81 90
ROCE % 39% 30% 21% 14% 1%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
40.56% 39.01% 39.00% 38.46% 38.43% 38.41% 38.41% 38.37% 37.90% 37.90% 37.77% 37.77%
1.93% 1.98% 1.73% 1.99% 0.68% 0.57% 0.18% 0.30% 0.19% 0.69% 1.14% 1.35%
1.93% 1.90% 1.92% 1.89% 2.13% 1.94% 0.89% 0.88% 0.92% 0.87% 0.43% 0.09%
55.58% 57.11% 57.35% 57.66% 58.78% 59.07% 60.52% 60.43% 60.99% 60.54% 60.65% 60.79%
No. of Shareholders 28,20731,98332,79934,53942,49743,10644,30245,84848,59849,05050,46050,022

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls